2015 sees a mixed verdict for IMF Bentham Ltd

Litigation funder IMF Bentham Ltd (ASX:IMF) reports weak results.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Litigation funder IMF Bentham Ltd (ASX: IMF) reported an uninspiring set of results for the year to 30 June 2015 yesterday. Total income was down 3.1% to $27 million whilst net profit fell 36.1% to $6.3 million. Dividends were maintained at 10 cents per share for the year placing the stock on a dividend yield of 6.3%.

It is important to note that although profit for the year was $6.3 million, there was also $8.7 million of unrealised foreign exchange gains included in the result. This means that had exchange rates moved the other way during the year, IMF would have produced a loss.

The first half of the year saw a strong net profit result of $23 million but in the second half the company recorded a loss of $17 million. The second half result was impacted by adverse rulings in two large cases, $5.5 million of losses related to the bank fees case and $8.4 million related to the National Potato Company case. Both these were lost on appeal where the original decision had gone the way of IMF and the company intends to re-appeal the bank fees case in 2016.

During the year IMF changed its chairman and chief executive and two other executive directors also left the board. Former managing director Hugh McLernon has been retained as an executive director.

IMF has only ever lost 10 cases out of 140 contested not including withdrawals. However four of these losses came in 2015 and another large loss of $13.7 million relating to the Bank of Queensland case was realised in 2014. As the company has grown, so too has the size of the cases it funds causing profits to be more volatile. Management is looking to address this issue by diversifying its case portfolio.

Part of this strategy is overseas expansion. The company opened its first overseas office in New York in 2011 and in May 2015 opened its third American office in San Francisco. Since inception, the United States business has contributed $20 million of net profit to the group.

IMF established a joint venture in Europe in 2014, opening an office in London and one in Amsterdam. It has also funded three cases in Hong Kong and plans to do more work in Asia.

Foolish takeaway

IMF's cases span many years and outcomes are uncertain. An investment in the company is really a bet on management's ability to manage this risk. Given the volatility inherent in the business and using history as a guide, it seems that in 2015 IMF got unlucky with the timing and decisions of a number of cases. Therefore the result is not a fair reflection on the true performance of the business.

Management advised that it expects to generate approximately $300 million in gross revenue from its current case portfolio over the next three years. However in 2015 it generated $92 million of gross revenue but still delivered a disappointing result. It is very difficult to pin down the true value of IMF which is why I do not own any shares in the company.

Motley Fool contributor Matt Brazier has no position in any stocks mentioned. You can find Matt on Twitter@MatthewBrazier1. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »